{"id":6433,"date":"2017-04-20T06:37:40","date_gmt":"2017-04-20T06:37:40","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/"},"modified":"2017-04-20T06:37:40","modified_gmt":"2017-04-20T06:37:40","slug":"arsredovisning-20160101-20161231","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/arsredovisning-20160101-20161231\/","title":{"rendered":"\u00c5rsredovisning 20160101-20161231"},"content":{"rendered":"<p><span>Se\u00a0 \u00e5rsredovisning som bifogad fil.<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information, v\u00e4nligen kontakta<\/strong><\/span><\/p>\n<p><span>Azad Najar, VD <\/span><\/p>\n<p><span>Tel: +46(0)736-673\u00a0463<\/span><\/p>\n<p><span>E-post:\u00a0<\/span><a href=\"mailto:azad.najar@realheart.se\" rel=\"nofollow\"><span>azad.najar@realheart.se<\/span><\/a>\u00a0<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><em><span>Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian Real Heart AB utvecklar en hj\u00e4rtpump (TAH) som efterliknar kroppens naturliga cirkulation och som ska kunna anv\u00e4ndas som en \u00f6verg\u00e5ngsl\u00f6sning f\u00f6r patienter som v\u00e4ntar p\u00e5 en hj\u00e4rttransplantation.<\/span><\/em><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/arsredovisning-2016.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2242552%2F659972.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/arsredovisning-2016.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2242552%2F659972.pdf&type=jpg\"><\/span>\u00c5rsredovisning 2016<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Se\u00a0 \u00e5rsredovisning som bifogad fil. F\u00f6r ytterligare information, v\u00e4nligen kontakta Azad Najar, VD Tel: +46(0)736-673\u00a0463 E-post:\u00a0azad.najar@realheart.se\u00a0 Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6433","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory-vpml"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c5rsredovisning 20160101-20161231 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c5rsredovisning 20160101-20161231 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Se\u00a0 \u00e5rsredovisning som bifogad fil. F\u00f6r ytterligare information, v\u00e4nligen kontakta Azad Najar, VD Tel: +46(0)736-673\u00a0463 E-post:\u00a0azad.najar@realheart.se\u00a0 Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/arsredovisning-20160101-20161231\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/arsredovisning-20160101-20161231\\\/\",\"name\":\"\u00c5rsredovisning 20160101-20161231 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2017-04-20T06:37:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/arsredovisning-20160101-20161231\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/arsredovisning-20160101-20161231\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/arsredovisning-20160101-20161231\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c5rsredovisning 20160101-20161231\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c5rsredovisning 20160101-20161231 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/","og_locale":"sv_SE","og_type":"article","og_title":"\u00c5rsredovisning 20160101-20161231 - Realheart","og_description":"Se\u00a0 \u00e5rsredovisning som bifogad fil. F\u00f6r ytterligare information, v\u00e4nligen kontakta Azad Najar, VD Tel: +46(0)736-673\u00a0463 E-post:\u00a0azad.najar@realheart.se\u00a0 Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian...","og_url":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/","url":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/","name":"\u00c5rsredovisning 20160101-20161231 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2017-04-20T06:37:40+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/arsredovisning-20160101-20161231\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"\u00c5rsredovisning 20160101-20161231"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}